KA
CELG

Kovack Advisors’s Celgene Corp CELG Stock Holding History

Kovack Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,030
Closed -$1.69M – 580
2019
Q3 		$1.69M Sell
17,030
-250
-1% -$23.8K 0.35% 67
2019
Q2 		$1.6M Buy
17,280
+7,491
+77% +$711K 0.37% 65
2019
Q1 		$923K Sell
9,789
-590
-6% -$51.6K 0.23% 115
2018
Q4 		$665K Sell
10,379
-2,856
-22% -$211K 0.19% 129
2018
Q3 		$1.18M Buy
13,235
+4,075
+44% +$360K 0.31% 83
2018
Q2 		$727K Sell
9,160
-1,278
-12% -$106K 0.2% 126
2018
Q1 		$931K Buy
10,438
+5,916
+131% +$568K 0.23% 106
2017
Q4 		$431K Sell
4,522
-441
-9% -$49.8K 0.11% 223
2017
Q3 		$724K Buy
4,963
+45
+0.9% +$6.13K 0.24% 104
2017
Q2 		$639K Sell
4,918
-2,178
-31% -$267K 0.2% 120
2017
Q1 		$883K Sell
7,096
-500
-7% -$59.8K 0.34% 63
2016
Q4 		$879K Sell
7,596
-1,249
-14% -$139K 0.42% 49
2016
Q3 		$924K Buy
8,845
+4,108
+87% +$445K 0.45% 51
2016
Q2 		$467K Sell
4,737
-220
-4% -$22.8K 0.25% 103
2016
Q1 		$496K Buy
4,957
+213
+4% +$21.9K 0.31% 88
2015
Q4 		$568K Sell
4,744
-29
-0.6% -$3.35K 0.37% 74
2015
Q3 		$516K Sell
4,773
-93
-2% -$11.5K 0.36% 72
2015
Q2 		$563K Sell
4,866
-172
-3% -$19.7K 0.4% 60
2015
Q1 		$581K Sell
5,038
-588
-10% -$70.3K 0.49% 47
2014
Q4 		$629K Buy
5,626
+2,721
+94% +$287K 0.65% 37
2014
Q3 		$275K Buy
+2,905
New +$262K 0.4% 57

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Kovack Advisors's CELG Position: Q4 2019 in Review

Kovack Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,030 shares — an estimated $1.69M sold.

Kovack Advisors first reported a position in CELG in Q3 2014 and held it in 21 quarters. The position peaked at $1.69M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Kovack Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Kovack Advisors sold 17,030 Celgene Corp shares in Q4 2019, an estimated $1.69M.
  • Kovack Advisors first reported a position in Celgene Corp in Q3 2014 and held it in 21 quarters.
  • Kovack Advisors's Celgene Corp position peaked at $1.69M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Kovack Advisors's 13F filing for Q4 2019, filed 29 Jan 2020.